AstraZeneca Plans $1.5 Billion Factory in Singapore as Drug Industry Splits From China
news via Business – TIME in Management & Business
Astra is working to ensure it can independently supply drugs to major markets as the U.S. pushes to reduce the industry’s reliance on China....
READ FULL ARTICLE »
Become a member to take advantage of more features, like commenting and voting.
Register or sign in today!